0

0

0

0

0

0

0

0

0

This article is more than 1 year old.

Dr Reddy's launches generic arthritis drug in US Market

Mini

Dr Reddy's Laboratories on Wednesday said it has launched overthecounter Diclofenac Sodium topical gel, used for arthritis pain, in the US market. The Hyderabadbased company's product is the generic version of Novartis Corporation's Voltaren gel.

Dr Reddy's launches generic arthritis drug in US Market
Dr Reddy’s Laboratories on Wednesday said it has launched over-the-counter Diclofenac Sodium topical gel, used for arthritis pain, in the US market. The Hyderabad-based company’s product is the generic version of Novartis Corporation’s Voltaren gel.
”The launch of product is an important addition to our pain/analgesics portfolio of over-the-counter (OTC) products, and represents our continued commitment to the private label OTC space,” Dr Reddy’s Laboratories North America Generics CEO Marc Kikuchi said in a statement. The company has partnered with Encube Ethicals to bring this product to market for the benefit of consumers, he added.
Also Read
Diclofenac Sodium topical gel is used for temporary relief of arthritis pain in hand, wrist, elbow, foot, ankle and knee. According to IRI data, the Voltaren brand had total retail sales of around USD 44 million since launch in May 2020.
next story